Why some organ allografts are tolerated better than others: new insights for an old question

被引:10
|
作者
Hull, Travis D. [1 ]
Benichou, Gilles [2 ]
Madsen, Joren C. [1 ,2 ,3 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Transplantat Sci, Boston, MA 02115 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Div Cardiac Surg, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
mechanisms; organ-specificity; tolerance; CLINICAL OPERATIONAL TOLERANCE; PLASMACYTOID DENDRITIC CELLS; LIVER-TRANSPLANT TOLERANCE; MESENCHYMAL STROMAL CELLS; MINIATURE SWINE; RENAL-ALLOGRAFTS; LONG-TERM; VITAMIN-D; KIDNEY-TRANSPLANTATION; HEME OXYGENASE-1;
D O I
10.1097/MOT.0000000000000594
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Purpose of review There is great variability in how different organ allografts respond to the same tolerance induction protocol. Well known examples of this phenomenon include the protolerogenic nature of kidney and liver allografts as opposed to the tolerance-resistance of heart and lung allografts. This suggests there are organ-specific factors which differentially drive the immune response following transplantation. Recent findings The specific cells or cell products that make one organ allograft more likely to be accepted off immunosuppression than another are largely unknown. However, new insights have been made in this area recently. Summary The current review will focus on the organ-intrinsic factors that contribute to the organ-specific differences observed in tolerance induction with a view to developing therapeutic strategies to better prevent organ rejection and promote tolerance induction of all organs.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 50 条